BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 10165439)

  • 1. Billing Medicare for investigational devices: what's OK, what's not.
    Gardner JR
    Healthc Financ Manage; 1997 Mar; 51(3):50-4. PubMed ID: 10165439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practical considerations for conducting effective billing audits.
    Bacon RF
    Healthc Financ Manage; 2002 Apr; 56(4):36-9. PubMed ID: 11963596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hospital fraud inquiry that fizzled.
    Pound ET; Headden S
    US News World Rep; 1995 Dec; 119(24):42. PubMed ID: 10153026
    [No Abstract]   [Full Text] [Related]  

  • 4. Compliance. What's around the corner?
    Showalter JS
    Healthc Financ Manage; 2003 Apr; 57(4):56-62. PubMed ID: 12735188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hospitals try to devise solutions in device debate.
    Scott L
    Mod Healthc; 1995 Feb; 25(8):34-6, 38. PubMed ID: 10140204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is contingency-fee consulting an endangered species?
    Russo JJ
    Healthc Financ Manage; 1997 Oct; 51(10):70-1. PubMed ID: 10173967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crozer-Keystone settles. Deal is first under probe into Medicare pneumonia billing.
    Bellandi D
    Mod Healthc; 1997 Nov; 27(47):6. PubMed ID: 10174839
    [No Abstract]   [Full Text] [Related]  

  • 8. Publication of the OIG compliance program guidance for hospitals--OIG. Notice.
    Fed Regist; 1998 Feb; 63(35):8987-98. PubMed ID: 10177742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The blind hog and the acorn: Medicare coverage for investigational devices.
    Betz R
    J Healthc Resour Manag; 1995 Mar; 13(3):31-2. PubMed ID: 10154864
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluating your risk for Medicare billing fraud.
    Loughran S
    Health Care Strateg Manage; 1998 Oct; 16(10):1, 20-3. PubMed ID: 10187604
    [No Abstract]   [Full Text] [Related]  

  • 11. America's most wanted ...
    Mustokoff M; Yecies M
    Health Syst Rev; 1996; 29(4):10-2. PubMed ID: 10162048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What managers need to know about Medicare fraud probes.
    OR Manager; 1997 Dec; 13(12):1, 9-10. PubMed ID: 10176786
    [No Abstract]   [Full Text] [Related]  

  • 13. IG's query finds hospitals bill Medicare for inappropriate costs.
    Nemes J
    Mod Healthc; 1992 Jun; 22(23):6. PubMed ID: 10118402
    [No Abstract]   [Full Text] [Related]  

  • 14. Consolidated billing and compliance program--Part 2.
    Stahl DA
    Nurs Manage; 1998 Jun; 29(6):12-5. PubMed ID: 9807420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The medical device payment controversy rages on.
    Brown E
    Physician Exec; 1995 Nov; 21(11):40-1. PubMed ID: 10153735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contingency arrangements do not necessarily equal fraud and abuse.
    Mohler JW; Wolf JD
    Healthc Financ Manage; 1998 Jul; 52(7):62-4. PubMed ID: 10180897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CMS investigates outlier payments.
    Brock TH
    Healthc Financ Manage; 2003 Feb; 57(2):70-4. PubMed ID: 12602315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HCFA implements new billing requirements for outpatient rehabilitation therapies.
    Natl Rep Subacute Care; 1998 Apr; 6(8):1, 3. PubMed ID: 10178936
    [No Abstract]   [Full Text] [Related]  

  • 19. Medicare and state health programs: fraud and abuse; issuance of advisory opinions by the OIG--HHS. Final rule.
    Fed Regist; 1998 Jul; 63(136):38311-26. PubMed ID: 10183348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Securing insurance protection against fraud and abuse liability.
    Callison S
    Healthc Financ Manage; 1999 Jul; 53(7):50-1. PubMed ID: 10558007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.